Results of the PURPOSE 1 trial indicated that a twice-yearly injection of lenacapavir outperformed the once-daily oral ...

AI is being utilized across the pharma industry, often in unique and unexpected ways. Aidoc announced its latest updates to ...

Michael Armstrong is CTO and co-founder at Authenticx, a company focused on building and training AI models for ...

Expansion of Elevidys includes patients over the age of four years with Duchenne muscular dystrophy regardless of their ...

Prime Therapeutics announced that it has partnered with Magellan Rx Management to launch a pharmaceutical platform for plan ...

Approval of Sofdra marks the first chemical entity to be approved by the FDA to treat primary axillary hyperhidrosis.

Thomas Rademacher is considered by some to be one of the founders of biotech. Most recently, he co-founded and serves as CEO ...

Approval for Capvaxive was based on results from three Phase III trials, which found Capvaxive to be beneficial preventing ...

Approval of Skyrizi marks the first IL-23 specific inhibitor approved for both ulcerative colitis and Crohn disease of ...

Alignment with Personal Values and Ethics: Those guided by strong personal values centered on kindness, compassion, and the ...

Gabi Hanna, MD, CEO and Co-Founder of Lamassu Pharma talks about a novel oncology platform and the link between science and ...

In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, ...